DHR announced a cash dividend of 0.27 with an ex-date of Jun. 29, 2023
|Bid||232.00 x 800|
|Ask||235.84 x 800|
|Day's Range||230.95 - 233.80|
|52 Week Range||221.22 - 303.82|
|Beta (5Y Monthly)||0.80|
|PE Ratio (TTM)||25.00|
|Earnings Date||Jul 19, 2023 - Jul 24, 2023|
|Forward Dividend & Yield||1.08 (0.47%)|
|Ex-Dividend Date||Jun 29, 2023|
|1y Target Est||276.57|
Subscribe to Yahoo Finance Plus to view Fair Value for DHRLearn more
Danaher (DHR) closed the most recent trading day at $232.21, moving +0.76% from the previous trading session.
With its stock down 8.6% over the past three months, it is easy to disregard Danaher (NYSE:DHR). But if you pay close...
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Short-term issues have pushed down the share price, but long-term opportunities look good
Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2).
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 28, 2023 to holders of record on June 30, 2023.
Key Insights The projected fair value for Danaher is US$258 based on 2 Stage Free Cash Flow to Equity With US$239 share...
It’s been a good year for Bill Gates. According to the Bloomberg Billionaires Index, the Microsoft (NASDAQ:MSFT) co-founder’s net worth is up $15.5 billion to $125 billion. The Seattle entrepreneur and philanthropist makes a significant amount from his Microsoft holdings. However, Bill Gates’ investing strategy also involves buying large positions in other well-run companies and holding them indefinitely. Google the words “Bill Gates stocks 2023” and you get more than 51 million results. In othe
In this article, we discuss 10 best scientific instruments stocks to buy. If you want to see more stocks in this selection, check out 5 Best Scientific Instruments Stocks To Buy. Scientific instruments are tools used to measure, record, and indicate physical quantities, aiding in scientific research and new product development. These instruments are designed […]
(Bloomberg) -- Catalent Inc. shares traded at their lowest in three years following cuts to its annual financial outlook that hurt investor confidence in the contract drug manufacturer.Most Read from BloombergPowell’s Bet Against Recession Looks Good — Minus the Credit Crunch and a DC StandoffTexas Mass Shooting’s Bloody Images Add to Fervor in Gun DebateWhy Airfares, Hotels and Cars Are Getting So Expensive for AmericansGoldman Shells Out $215 Million to End Case on Underpaying WomenMitch McCon
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 10, 2023 at 10:00 a.m. PT. The audio will be simultaneously webcast on www.danaher.com.
Insiders at Danaher Corporation ( NYSE:DHR ) sold US$4.5m worth of stock at an average price of US$270 a share over the...
Danaher Corporation (NYSE:DHR) Q1 2023 Earnings Call Transcript April 25, 2023 Danaher Corporation beats earnings expectations. Reported EPS is $2.36, expectations were $2.25. Operator: My name is Ashley and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to Danaher Corporation’s First Quarter 2023 Earnings Results Conference […]
SVB Securities analyst Puneet Souda launched coverage of the stock with a target of $300 for the price.
Aldevron, a leading global manufacturer of DNA, RNA and proteins used in cell and gene therapies and vaccine development, will expand its mRNA production capabilities to include lipid nanoparticle (LNP) encapsulation and aseptic fill-finish capabilities enabling mRNA cGMP manufacturing services from Master Cell Bank through to Drug Product. This new capability will support the production of therapeutic-scale clinical and commercial-stage mRNA therapies for cancers and genetic diseases, and clini
If you’re interested in investing in water tech stocks, you’d be wise to turn to Invesco. It’s cornered the market on water technology companies, marketing three of the top water exchange-traded funds (ETFs) listed on U.S. stock exchanges: Invesco Water Resources ETF (NASDAQ:PHO), Invesco S&P Global Water Index ETF (NYSEARCA:CGW) and Invesco Global Water ETF (NASDAQ:PIO). According to an Invesco white paper, global water resources fell by 56% between 1962 and 2014. Water scarcity solutions have
Honeywell's (HON) Q1 results benefit from strong performance of the Aerospace segment due to higher commercial aviation aftermarket sales. The company's improved guidance for 2023 holds promise.
Healthcare stocks are one of the best bets out there. The U.S. spends more on healthcare than any other country. In 2021, America spent 17.8% of its gross domestic product on healthcare, nearly twice as much as the average among OECD nations. Health spending per person in the U.S. was $12,914 in 2021, which was about $5,000 more than any other developed country. All told, the U.S. spends more than $4 trillion each year on healthcare, making it one of the leading sectors of the world’s biggest ec
Stocks got off to a tough start on Tuesday, as market participants looked closely at the latest slate of earnings results. United Parcel Service (NYSE: UPS) is a stalwart of the shipping industry, and its numbers say a lot about whether the e-commerce side of the consumer retail economy is firing on all cylinders. Meanwhile, Danaher (NYSE: DHR) gave its reading on the healthcare sector.
Danaher Corp (NYSE: DHR) has logged Q1 FY23 adjusted EPS of $2.36, down from $2.76 a year ago, surpassing the consensus of $2.25. Sales decreased 7% Y/Y to $7.17 billion, beating the consensus of $7.02 billion, with a 4% non-GAAP core revenue decrease, due to lower COVID-19 revenue and 6.0% non-GAAP base business core revenue growth. Operating cash flow for Q1 FY23 reached $1.9 billion. Non-GAAP free cash flow reached $1.7 billion. Rainer M. Blair, President & CEO, stated, "We had a good start t
Danaher's (DHR) Q1 earnings and revenues beat estimates. However, a decline in the sale of COVID-related products weigh on the top line.
While the top- and bottom-line numbers for Danaher (DHR) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Danaher (DHR) delivered earnings and revenue surprises of 4.42% and 1.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?